Board Member
Spyre Therapeutics, Inc. (SYRE)Equibles does not estimate personal net worth.
Get an email with a short summary when Spyre Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get SYRE alertsCameron Turtle, DPhil is recorded as CEO and Board Member at Spyre Therapeutics, Inc. (SYRE) since November 22, 2023. Cameron Turtle, DPhil has spoken on 1 investor event across 1 company, most recently for Spyre Therapeutics, Inc. on June 8, 2026. Spyre Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Spyre Therapeutics, Inc. includes Cameron Turtle (CEO, COO and Board Member), James Kastenmayer (CEO), Jeffrey M. Goldberg (CEO) and 7 others.
“So as a brief background, Spire is a company that's aiming to improve the standard of care across a range of autoimmune diseases.”
2023-11-22–present
2023-11-22–present
Biotechnology · Healthcare
CEO, Board Member
2023-11-22–present
